Jun 04, 2020
IRLAB's Phase IIb/III Study in Parkinson's disease to Target Good ON
Feb 27, 2020
Renishaw announces completion of the main part of a multi-centre clinical trial jointly undertaken with Herantis Pharma for the treatment of Parkinson's Disease patients
Sep 25, 2019
Intec Pharma Highlights Potential of Accordion Pill® Oral Drug Delivery Platform in Two Posters at International Congress of Parkinson's and Movement Disorder Society
Sep 16, 2019
Intec Pharma to Present Two Posters at International Congress of Parkinson's and Movement Disorder Society
Aug 19, 2019
Boston Scientific Announces FDA Approval Of ImageReady(TM) MRI For Vercise Gevia(TM) Deep Brain Stimulation System
Jul 22, 2019
Intec Pharma Reports Top-Line Phase 3 Trial Results of Accordion Pill-Carbidopa/Levodopa in Advanced Parkinson's Disease Patients
Jun 19, 2019
Intec Pharma Announces Results From Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Were Presented at the XXIV World Congress on Parkinson's Disease and Related Disorders
May 02, 2019
Intec Pharma's Data from Pharmacokinetic Study of AP-CD/LD 50/500 mg Dosed Three Times Daily Accepted for Presentation at the XXIV World Congress on Parkinson's Disease and Related Disorders
Apr 30, 2019
Intec Pharma Reports Last Patient Last Visit in Pivotal Phase 3 Trial of Accordion Pill(TM) Carbidopa/Levodopa for the Treatment of Advanced Parkinson's Disease Patients
Feb 19, 2019
Intec Pharma Reports Positive Results from Pharmacokinetic Study of Accordion Pill(TM) Carbidopa/Levodopa 50/500 mg Dosed Three Times Daily
Jan 24, 2019
Boston Scientific Launches Vercise(TM) Primary Cell And Vercise Gevia(TM) Deep Brain Stimulation Systems With Directional Leads
Jan 15, 2019
Theracycle Partners with Virginian Outpatient Therapy to Replicate Innovative Study on Forced Exercise for Parkinson's Patients
Jan 07, 2019
Kainos Medicine Reaches Milestone in Bringing "KM-819" Treatment for Parkinson's Disease to Market
Dec 19, 2018
Intec Pharma Publishes Letter to Shareholders
Oct 22, 2018
Intec Pharma Completes Enrollment of Pivotal Phase 3 Clinical Trial of Accordion Pill(TM) Carbidopa/Levodopa for the Treatment of Advanced Parkinson's Disease Patients
Sep 25, 2018
Intec Pharma to Present Multiple Posters at International Congress of Parkinson's and Movement Disorder Society
Aug 15, 2018
Neurocrine Biosciences to Present Data on INGREZZA® (valbenazine) and Opicapone at the 2018 World Congress on Parkinson's Disease and Related Disorders
Jun 21, 2018
Deep Brain Stimulation Devices Market Size Worth $2.10 Billion by 2025: Grand View Research, Inc.
May 31, 2018
Intec Pharma to Present at Jefferies 2018 Healthcare Conference
Apr 24, 2018
Intec Pharma Presented Phase 1 PK and Safety Data From Accordion Pill Carbidopa/Levodopa at American Academy of Neurology Annual Meeting